Related Experiment Video
Updated: May 2, 2026

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
Primary mediastinal seminoma; resistance and relapse: An aggressive entity
Ankita Nachankar1, Rahul Krishnatry1, Amit Joshi2
1Department of Radiation Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Abstract:
Seminoma is one of the most radio and chemo sensitive tumors. Aggressive variant of primary mediastinal seminoma (PMS) are rarely described in the literature. We here discuss an interesting case of young male (22 years) presenting with superior vena cava syndrome due to PMS that showed poor response to conventional platinum based chemotherapy and radiotherapy. Furthermore, with a short disease free interval (one year) relapsed at unusual sites of bone and soft-tissue deposits in check. This emphasizes the importance of identifying methods to pre-screen such aggressive variants for more effective treatment options.
More Related Videos
Related Concept Videos
Treatment Resistent Cancers
Treatment Resistant Cancers

